Jiang, Y., Liu, Y., Xiao, Y., Hu, X., Jiang, L., Zuo, W., . . . Shao, Z. (2020). Molecular subtyping and genomic profiling expand precision medicine in refractory metastatic triple-negative breast cancer: The FUTURE trial. Cell Res.
Style de citation ChicagoJiang, Yi-Zhou, et al. "Molecular Subtyping and Genomic Profiling Expand Precision Medicine in Refractory Metastatic Triple-negative Breast Cancer: The FUTURE Trial." Cell Res 2020.
Style de citation MLAJiang, Yi-Zhou, et al. "Molecular Subtyping and Genomic Profiling Expand Precision Medicine in Refractory Metastatic Triple-negative Breast Cancer: The FUTURE Trial." Cell Res 2020.
Attention : ces citations peuvent ne pas être correctes à 100%.